2-(Trifluoromethyl)-5,6,7,8-tetrahydro-8-methyl-[1,2,4]triazolo[1,5-a]pyrazine is a heterocyclic compound characterized by its complex structure, which includes a triazole and pyrazine moiety. The presence of a trifluoromethyl group enhances its lipophilicity and may influence its biological activity, making it of interest in pharmaceutical research. The tetrahydro component indicates that the compound has a saturated ring system, contributing to its stability and potentially affecting its reactivity. The methyl group at the 8-position can also impact the compound's steric and electronic properties. This compound may exhibit unique interactions with biological targets, making it a candidate for further investigation in medicinal chemistry. Its specific properties, such as solubility, melting point, and reactivity, would depend on the overall molecular structure and functional groups present. As with many heterocycles, it may also display interesting pharmacological activities, warranting further study in drug development contexts.

2-(trifluoromethyl)-5,6,7,8-tetrahydro-8-methyl-[1,2,4]triazolo[1,5-a]pyrazine

781614-02-6: 2-(Trifluoromethyl)-5,6,7,8-tetrahydro-8-methyl-[1,2,4]triazolo[1,5-a]pyrazine is a heterocyclic compound characterized by its complex structure, which includes a triazole and pyrazine moiety. The presence of a trifluoromethyl group enhances its lipophilicity and may influence its biological activity, making it of interest in pharmaceutical research. The tetrahydro component indicates that the compound has a saturated ring system, contributing to its stability and potentially affecting its reactivity. The methyl group at the 8-position can also impact the compound's steric and electronic properties. This compound may exhibit unique interactions with biological targets, making it a candidate for further investigation in medicinal chemistry. Its specific properties, such as solubility, melting point, and reactivity, would depend on the overall molecular structure and functional groups present. As with many heterocycles, it may also display interesting pharmacological activities, warranting further study in drug development contexts.

CAS 781614-02-6

2-(trifluoromethyl)-5,6,7,8-tetrahydro-8-methyl-[1,2,4]triazolo[1,5-a]pyrazine

8-Methyl-2-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyrazine

Ref: IN-DA0054SX